Directors' Dealings
December 18 2007 - 7:51AM
UK Regulatory
RNS Number:1788K
Immupharma PLC
18 December 2007
For Immediate Release 18 December 2007
ImmuPharma PLC
Directors' Dealing
Powe Capital increases stake in ImmuPharma to over 5%
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), announces today that
Powe Capital, through its funds Modulus Europe and Tensor Europe, has increased
its stake in ImmuPharma from 3.12% to 5.59% through a purchase, on 14 December
2007, of 1,800,000 existing ordinary shares of 10 pence each in the Company from
the Trusts of two of ImmuPharma's founders and Directors, Richard Warr and
Dimitri Dimitriou.
The subsequent interests are as follows:
Shares Price per Subsequent beneficial Subsequent percent
purchased share holding interest
Modulus 1,540,000 �0.73 3,808,127 5.23%
Europe
Tensor 260,000 �0.73 260,000 0.36%
Europe
Shares Price per Subsequent beneficial Subsequent percent
placed share holding interest
Richard Warr 900,000 �0.73 11,878,968 16.32%
(1)
Dimitri
Dimitriou(2) 900,000 �0.73 11,878,969 16.32%
(1) Ordinary shares of �0.10 held by Louvre Trustees where the Warr family has a
beneficial interest.
(2) Ordinary shares of �0.10 held by Louvre Trustees where the Dimitriou family
has a beneficial interest.
Richard Warr, ImmuPharma's Chairman said: "Powe Capital has been a longstanding
supporter and shareholder of ImmuPharma. We are delighted by the confidence they
have shown in the Company by increasing their stake to over 5%."
For further information please contact:
ImmuPharma PLC:
Richard Warr, Chairman +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Buchanan Communications +44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Panmure Gordon & Co
Andrew Burnett +44 151 243 0963
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFFAFEASWSELE
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024